Relmada Therapeutics (RLMD) Other Non Operating Income (2014 - 2020)

Relmada Therapeutics (RLMD) has 7 years of Other Non Operating Income data on file, last reported at -$934919.0 in Q1 2020.

• On a quarterly basis, Other Non Operating Income fell 46746050.0% year-over-year to -$934919.0 in Q1 2020; TTM through Mar 2020 was -$671010.0, a 20.5% increase from a year earlier, with the FY2019 full-year figure at -$54634.0, up 92.29% from the prior year.
• Other Non Operating Income for Q1 2020 stood at -$934919.0, down from $2.0 in the prior quarter.
• Over the last five years, Other Non Operating Income for RLMD reached as high as $13.0 million in Q2 2016 and fell as low as -$934919.0 in Q1 2020.
• Historically, Other Non Operating Income has averaged $883366.9 across 5 years, with a median of $28455.5 in 2016.
• Across the five-year window, Other Non Operating Income jumped 7840.17% in 2016 and slumped 46746050.0% in 2020, its largest moves.
• Year by year, Other Non Operating Income stood at $56909.0 in 2016, then jumped by 499.39% to $341106.0 in 2017, then fell by 22.63% to $263907.0 in 2018, then sank by 100.0% to $2.0 in 2019, then slumped by 46746050.0% to -$934919.0 in 2020.
• Per Business Quant data, the three most recent Other Non Operating Income figures were -$934919.0 in Q1 2020, $2.0 in Q1 2019, and $263907.0 in Q4 2018.